Skip to main navigation

Skip to primary navigation
Skip to main content
Skip to primary sidebar
Skip to footer

VectivBio

Transforming Lives

Site - Header Menu

About Us
Our Focus
Investors & Media
Contact Us
- Careers

Events & Presentations

Latest Presentation

Corporate Presentation

-

Upcoming Events

There are no upcoming events available at this time.

Past Events

May 11, 2022 at 4:40 PM PDT

Bank of America 2022 Healthcare Conference

Click here for webcast

Apr 7, 2022 at 8:00 AM EDT

Vectiv Bio Full Year 2021 Financial Results and Company Update

Click here for webcast

Feb 17, 2022 at 1:40 PM EST

2022 SVB Leerink Global Healthcare Conference

Click here for webcast

Nov 11, 2021 at 9:40 AM EST

Credit Suisse 30th Annual Healthcare Conference

Click here for webcast

Sep 23, 2021

SVB Leerink CybeRX Series: Neuromuscular, Rare Diseases & Genetic Medicines 1x1 Event

Sep 21, 2021 at 10:00 AM EDT

VectivBio R&D Day

Click here for webcast

R&D Day presentation 3.5 MB

Sep 2, 2021 at 8:00 AM EDT

Extraordinary General Meeting

Minutes 149.1 KB

Scientific Publications

A Phase 1, Open-Label Evaluation of the Pharmacokinetics and Safety of a Single Dose of Apraglutide in Subjects with Normal and Impaired Renal Function: 2022 American Society for Parenteral and Enteral Nutrition. Seattle, Washington

March 29, 2022

Apraglutide Does Not Impact Anti-tumor and Immunosuppressive Efficacy of Conditioning Chemotherapy in Mice Presentation Location: The European Society for Blood and Bone Marrow Transplantation (EMBT) Annual Meeting 2022. Prague, Czech Republic

March 23, 2022

Apraglutide Decreases Severity of Intestinal Damage from Gastrointestinal (GI) Acute Graft Versus Host Disease(GvHD) Following Allogeneic Transplantation Without Impacting Engraftment Presentation Location: The European Society for Blood and Bone Marrow T

March 22, 2022

Apraglutide Treatment Reduces Chemotherapy-Induced Gastrointestinal (GI) Damage in Mice and Preserves Cellular Integrity During Chemotherapy Presentation Location: The European Society for Blood and Bone Marrow Transplantation (EMBT) Annual Meeting 2022.

March 22, 2022

Treatment with Apraglutide Preserves the Global Homeostatic Environment of Intestinal Microbiota During Chemotherapy in Mice Presentation Location: The European Society for Blood and Bone Marrow Transplantation (EMBT) Annual Meeting 2022. Prague, Czech Re

March 22, 2022

Primary Sidebar

INVESTORS & MEDIA

Overview
News & Media
- Press Releases
Events & Presentations
Annual General Meeting
Financial Information
Stock Information
Corporate Governance
Shareholder Resources

Site - Shareholder Tools

Email Alerts Print Search

IR CONTACT

ir@vectivbio.com

Footer

Site - Footer Menu Left

Site - Footer Menu Center

Terms of Use Privacy Policy

Copyright © VectivBio AG, 2022. All Rights Reserved.

Site - Footer Menu Right

About Us
Our Focus
Investors & Media
Contact Us

Site - Header Menu

About Us
Our Focus
Investors & Media
Contact Us
- Careers